Guidant Corp. said Tuesday the U.S. Food and Drug Administration sent the company a warning letter about unresolved problems it found during an inspection earlier this year at the medical device maker’s St. Paul, Minn., facility.
The Indianapolis-based company said the letter notes several remaining manufacturing or quality-control deficiencies. The inspection was completed Sept. 1.
